From the Sector

INDA is warmly remembering CK Wong, a veteran of the nonwovens industry for more than five decades and long-time member of INDA’s Board of Directors and Executive Committee. Wong passed away on March 22, 2024 at the age of 86.

Wong recognized the importance of the emerging nonwovens industry in the early 1970s. He began his career in the 1980s as a marketing consultant and, one year later, Wong set up his corporate headquarters in Hong Kong to convert nonwoven roll goods into disposable medical and industrial protection products. Over the past 35 years, Wong’s business grew to include household, beauty salon, sports applications, and other value-added products.

In 1994 Wong’s company officially became U.S. Pacific Nonwovens Industry Limited. His business expanded with a new converting plant in Dongguan, China, and in 2007 he invested in an adjacent building to handle his growing business. In 2018 Wong’s business broadened to include manufacturing PLA nonwovens. In addition to converted products, Wong’s business provided sales, service, and training for nonwovens equipment.

Wong was an active member at INDA since the late 90s. He served as Vice Chair of Finance on the Board of Directors for many years before becoming an Appointee on INDA’s Executive Committee. Wong was instrumental in helping INDA set up partnerships with key contacts and associations in China. He was also the Honorable Chairman for the Guangdong Nonwovens Association (GDNA) and the China Nonwovens & Industrial Textiles Association (Spunbond Division).

Re:NewCell AB announced that the Stockholm District Court has decided to approve the previously communicated bankruptcy application and has declared the company bankrupt.

The appointed bankruptcy trustee is lawyer Lars-Henrik Andersson at Cirio Advokatbyrå.

February,25 the Board of Directors had decided to file for bankruptcy of Re:NewCell AB at the Stockholm District Court. The reason for the decision to file for bankruptcy was that Re:NewCell has not been able to secure sufficient financing to complete the strategic review, announced on 20 November 2023, with satisfactory result.

As part of the strategic review, Re:NewCell has had well advanced negotiations with its two largest shareholders, H&M and Girindus, its existing lenders BNP Paribas, European Investment Bank, Finnvera (as partial guarantor), Nordea, AB Svensk Exportkredit and potential new investors as well as other stakeholders regarding long-term financing solutions. These discussions have not resulted in a solution which would provide Re:NewCell with the necessary liquidity and capital to ensure its operations going forward.

"I regret to inform that we have been forced to take this decision to file for bankruptcy. As we have a strong belief in the company’s long-term potential, we have together with our advisors spent very substantial time and efforts into trying to secure the necessary liquidity, capital and ownership structure for the company to secure its future. As part of the negotiations, we have had intense dialogues with both current main owners, new investors and our banks, as well as other stakeholders. However, these discussions have not been successful. This is a sad day for the environment, our employees, our shareholders, and our other stakeholders, and it is a testament to the lack of leadership and necessary pace of change in the fashion industry” says Chairman of the Board of Directors, Michael Berg.

RadiciGroup announced the appointment of Stefano Pigozzi to the Board of Directors of Radici Partecipazioni SpA, the parent company overseeing all the Group's business activities in the chemicals, engineering polymers and advanced textile solutions sectors.
 
A professional with proven experience in the chemical industry, Mr. Pigozzi will complement the Board with his strategic vision acquired in international organizations.
 
Stefano Pigozzi graduated from the University of St. Gallen in Switzerland with a degree in Business Administration and started his work experience in the finance division of BASF in the late 1980s. Since then, chemistry has remained at the centre of his career: over the years, he has held marketing and sales positions of increasing responsibility in various business sectors (plastics and inorganics), moving up to more strategic and managerial roles within BASF, including president of the Monomers Division and, most recently, head of the Group Global Purchasing Division at the Ludwigshafen headquarters.
 
During his more than 30-year career at BASF, Mr. Pigozzi has consistently demonstrated his leadership capability, his financial analysis skills and his dedication to corporate business success. He has also contributed significantly to the positioning of BASF as a global leader in the chemical industry.
 
Mr. Pigozzi’s appointment to the Board of Directors of Radici Partecipazioni is aimed at strengthening RadiciGroup's presence in the market and helping to guide the company towards new goals.

Highlights

• Net sales in the third quarter of 2023 were down by -20.3% organically versus a record Q3 2022 as expected due to -15% lower volumes (€-512 million) in a weaker macro environment and -5% lower prices (€-188 million) in a context of lower raw material costs and energy prices. On a sequential basis, net sales were down -11% versus Q2. The volume reduction was broad based across regions and businesses.
• Structural cost savings for the first nine months of 2023 amounted to €63 million, bringing the total savings since 2019 to €530 million.
• Underlying EBITDA of €702 million in Q3 2023 was down by -18.5% organically compared to a record Q3 2022 driven by lower volumes, partly offset by €36 million in positive net pricing and €41 million in lower fixed costs. Nine months EBITDA at €2,331 million is only down -1% organically versus 2022, a clear indication that strong historic pricing and cost discipline momentum is being maintained.
• The underlying EBITDA margin of 25.6% in Q3 2023 was sustained relative to Q3 2022 despite lower volumes, while nine months EBITDA margin of 25.9% is +1.3pp higher, mainly as a result of positive net pricing and cost discipline.
• Underlying Net Profit was €340 million in Q3 2023 compared to €509 million in Q3 2022.
• Free Cash Flow of €346 million in Q3 2023 resulted in a nine-month 2023 total of €1,027 million and a FCF conversion ratio of 39.4%.
• ROCE was 15.2%, broadly in line with Q3 2022.
• Continued strengthening of the balance sheet with underlying net debt at €2.8 billion, which translated to a historic low leverage of 0.9x.
• As explained on page 2, an interim dividend of €1.62 gross per share has been validated by the Board of Directors, in line with historical interim dividend policy to be paid by Solvay SA on January 17, 2024.

2023 Outlook
Given the current volume momentum, Solvay reconfirm their full year guidance, at the lower end of the prior EBITDA guidance range.

Solvay announced the future Board of Directors of SYENSQO, effective upon completion of the planned separation of Solvay into two companies – SOLVAY and SYENSQO – which is on track to be completed in December 2023.

SYENSQO’s Board will be composed of 10 members, including 6 independent members, 3 members representing the reference shareholder, Solvac, and the company CEO. They have deep expertise in specialty industries, international business operations, risk management, corporate governance, finance and clean technology.

The following individuals will serve on the SYENSQO Board of Directors:
Rosemary Thorne will serve as independent Director and Chair of the SYENSQO Board, as well as Chair of the Board’s Finance Committee. She is currently an Independent Director on the Solvay Board of Directors, appointed in 2014, and Chair of the Board’s Audit Committee. She is also an Independent Director on the Board of Merrill Lynch International (UK), a wholly-owned subsidiary of Bank of America, serving as Chair of the Audit Committee. Ms. Thorne has decades of financial leadership experience across a wide range of industries. She previously served as Chief Financial Officer at J. Sainsbury, the UK’s largest supermarket chain at the time; Bradford & Bingley; and Ladbrokes. Ms. Thorne previously sat as an Independent Director on the Boards of Royal Mail Group, Cadbury Schweppes, Santander UK, First Global Trust Bank and Smurfit Kappa Group.

Dr. Ilham Kadri will serve as Chief Executive Officer and member of the Board of Directors of SYENSQO. She is currently CEO and President of the Executive Committee at Solvay. Ms. Kadri has successfully led the turnaround of Solvay, delivering double-digit EBITDA growth and 18 consecutive quarters of positive free cash flow, deleveraging the balance sheet and promoting superior people engagement. She is an independent Board member at A.O. Smith and L’Oréal. She is active in non-profit organizations, as Chair of the World Business Council for Sustainable Development (WBCSD), member of the steering committee of the European Round Table of Industrialists (ERT) as well as a permanent member of the World Economic Forum’s International Business Council (WEF). Ms. Kadri has extensive leadership experience across a variety of industries in four continents and with leading industrial multinationals, including Shell, UCB, Huntsman, Dow, Sealed Air. Prior to Solvay, she was CEO and President of Diversey in the USA, led the company’s return to profitability and resulting spin off and divestiture to Bain Capital. She founded two non-Profit foundations: the Solvay Solidarity Fund in Belgium in 2020 which supported more than 7000 families affected by Covid-19 and natural disasters; and founded the ISSA Hygieia Network in 2015 in the USA, to help women in the cleaning industry. She received two Doctor Honoris Clausa from EWHA University in Korea and Université de Namur in Belgium.

Julian Waldron will serve as independent Director and Chair of the Audit Committee. He currently serves as Deputy Executive Chairman of privately-held Albea Group, a global beauty and personal care packaging company which operates 35 facilities in Europe, Asia and the Americas. Mr. Waldron has held senior leadership roles at several leading listed companies in the industrial, technology and services sectors and brings a wealth of expertise in finance and business operations. Prior to joining Albea in 2022, he was Chief Financial Officer of Suez for three years after serving as Chief Financial Officer and subsequently Chief Operating Officer of Technip. He started his career at UBS Warburg where he spent 14 years. Mr. Waldron also served as an independent Board member and Chairman of finance, risk and investments at Carbon Clean, a privately-owned carbon capture company dedicated to achieving net zero.

Heike Van de Kerkhof will serve as independent Director and Chair of the Nomination Committee. She currently sits on the Board of OCI N.V.. Ms. Van de Kerkhof brings more than 30 years of experience in the chemicals, oil & gas and materials industries, having served in numerous leadership roles around the globe. From 2020 to 2023, she was Chief Executive Officer of Archroma Management, a global specialty chemicals company. During her tenure, she successfully completed the transformational acquisition of Huntsman’s Textile Effects business. Prior to her role at Archroma, Ms. Van de Kerkhof served as Vice President of Lubricants, Western Hemisphere at BP, and held positions at Castrol, The Chemours Company, and Neste Corporation. She also held many leading roles within DuPont over 18 years.

Matti Lievonen will serve as independent Director and Chair of the Compensation Committee. He is currently an independent director on the Solvay Board, appointed in 2017. Mr. Lievonen is a proven executive in the energy, forestry, power and automation industries with an extensive track record of leading businesses through climate transition. For over ten years until 2018, he served as Chairman and Chief Executive Officer of Neste Corporation, a global leader in next-generation renewable fuels and chemicals. During his time at Neste, Mr. Lievonen successfully promoted the development of clean fuels as well as Finland’s bioeconomy strategy in advancing renewable transportation fuels. He has also been involved with organizations such as Fortum Board, SSAB, Nynäs AB, Ilmarinen, and the HE Finnish Fair Foundation. Until 2021, Mr. Lievonen was also Chairman of the Board of Directors at Fortum. He has been recognized for his admirable leadership and expertise, and in 2016 was awarded an Honorary Doctorate of Technology by the Aalto University Schools of Technology.

Dr. Françoise de Viron will serve as non-independent Director, Chair of the ESG Committee and Vice-Chair of the Board. She is currently a director of the Solvay Board, appointed in 2013. Ms. de Viron is a regarded academic leader and has extensive experience in innovation, R&D and qualitative research. She is a Professor Emeritus at the Faculty of Psychology and Education Sciences and Louvain School of Management at UCLouvain in Belgium where she has been an Academic Member of various groups at UCLouvain. Ms. de Viron previously served as the president of AISBL EUCEN – the European Universities Continuing Education Network. Prior to her university position, from 1985 to 2000, she was in charge of developing Artificial Intelligence applications at Tractebel S.A. (now Tractebel-Engie).

Roeland Baan will serve as independent Director. He currently serves as President and Chief Executive Officer of Topsoe, a privately-held leading provider of clean energy and petrochemical technologies. He is also Chairman of the Supervisory Board of SBM Offshore NV. Roeland Baan has extensive experience in supply chain management, M&A, business development and operations management. Prior to joining Topsoe in 2020, he was President and CEO of Outokumpu and has held several executive roles at global organizations such as Aleris International, ArcelorMittal and SHV NV. He spent over 16 years in various roles across the globe at Shell, living in South America, in Africa and in the United Kingdom.

Edouard Janssen will serve as non-independent Director. He is currently a Director on the Solvay Board, appointed in 2021. Earlier this year, he was appointed Chief Financial Officer of D’Ieteren Group, a European leader in automotive distribution services. Mr. Janssen is also a Board member of privately-held Financière de Tubize and Union Financière Boël, as well as Co-Founder and Chair of Trusted Family. Mr. Janssen is active in academics, as Vice-Chair of the International Advisory Board of the Solvay Brussels School of Economics and Management and on the advisory board of the INSEAD HGIBS. He brings expertise in finance, strategy, entrepreneurship, business management, planning and marketing. He has served as Solvay’s Vice President in strategy and M&A between 2019 and 2021, and prior to that, he was the US-based General Manager for North- and Latin America at Solvay’s Aroma Performance Global Business Unit.
 
Dr. Mary Meaney will serve as non-independent Director. She is currently a member of the Board of Directors and of the Audit Committee of Groupe Bruxelles Lambert SA. She also sits on the Board of Directors and the Remuneration Committee of Beamery, the privately-held talent management company. She is a member of the Board of Directors and of the Finance Committee of Imperial College, London.Dr. Meaney will bring expertise in Strategy, M&A, and change management, which she acquired over a 24-year career at McKinsey. She was a Senior Partner, served on the McKinsey Shareholders Council and led McKinsey’s global Organization practice.

Nadine Leslie will serve as independent Director and is based in the United States of America. She is currently a member of the Board of Directors of Provident Financial Services , as well as a Non-Executive Director of Seven Seas Water Corporation, a water and wastewater treatment multinational company. She also sits on the Board of Trustees of Hackensack Meridian Health Network and is active as strategic consultant for civil engineering firm T&M Associates. Over a 22-year career at Suez, Ms. Leslie held several leadership positions, the last one being Chief Executive Officer of Suez North America, until 2022. Previously she served as Executive Vice President Health & Safety.

At the association’s General Assembly held on July 4th, Marco Salvadè has been appointed to replace Alessandro Zucchi as President of ACIMIT.

Marco Salvadè began his career at Salvadè Srl, the family company specializing in the finishing machinery sector, founded by his father and uncle in 1967. After being a member of the company’s board of directors, he has been President since 2021.

Following the election of Salvadè, the General Assembly expressed its gratitude to the outgoing president, Alessandro Zucchi, who has guided the association for the past six years.

Along with the new president, the General Assembly also elected its new Vice Presidents, Chiara Bonino (Bonino Carding Machines SRL), Federico Businaro (Sperotto Rimar SRL), Ugo Ghilardi (Itema SpA) and Cristian Locatelli (Marzoli Machines Textile SRL). Marco Salvadè’s first comments as newly appointed ACIMIT president: “I wish to thank the Assembly for the trust they have placed in me, and I want to express my gratitude to the former President Alessandro Zucchi for everything he has done during the last six years to strengthen the role of the association and of Italian industry on the international scene. With the new vice-presidents and the ACIMIT Board, I will continue the work that has been done in recent years by previous presidents. It will certainly not be a simple task, but one that will no doubt prove stimulating. My primary goal is to increase the sense of belonging to ACIMIT of its member companies, with which we share the same values, and to adjust the association’s strategies to changing conditions in the economic and geopolitical context.”

Shareholders Adopt All Motions Proposed by the Board of Directors

• Distribution of a dividend of CHF 1.50 per share approved
• Remuneration Report 2022 and future remuneration of Board of Directors and Group Executive Committee formally accepted
• All members of the Board of Directors who stood for re-election were elected
• Thomas Oetterli newly appointed to the Board of Directors
• KPMG newly elected as statutory auditors
• Amendments to the Articles of Association approved

On April 20, 2023, 325 shareholders, who represent 66.2% of the share capital, attended the 132nd Annual General Meeting of Rieter Holding Ltd.

Dividend
The shareholders approved the proposal of the Board of Directors to distribute a dividend of CHF 1.50 per share. The dividend for the 2022 financial year will be paid on April 24, 2023.

Annual Report, Financial Statements, Consolidated Financial Statements and Remuneration Report
The shareholders also adopted all other motions proposed by the Board of Directors, namely approval of the annual report, financial and consolidated financial statements for 2022. Moreover, they formally approved the actions of the members of the Board of Directors and those of the Group Executive Committee in the year under review.

By way of a consultative vote, the shareholders also approved the Remuneration Report 2022.

Remuneration of the Members of the Board of Directors and the Group Executive Committee
In two separate binding votes, the proposed maximum total remuneration of the members of the Board of Directors and the Group Executive Committee for the 2024 financial year was approved.

Re-Election of the Members of the Board of Directors
The Chairman of the Board, Bernhard Jucker, and the Directors, Hans-Peter Schwald, Peter Spuhler, Roger Baillod, Carl Illi, Sarah Kreienbühl and Daniel Grieder were confirmed for a further one-year term of office. In addition, Thomas Oetterli was newly elected to the Board of Directors for a term of office.

The members of the Remuneration Committee who were standing for election –
Hans-Peter Schwald, Bernhard Jucker and Sarah Kreienbühl – were likewise re-elected for a one-year term of office.

Election of KPMG as Statutory Auditors
The shareholders also adopted the proposal of the Board of Directors to elect KPMG AG, Zurich, as new statutory auditors for the financial year beginning January 1, 2023.

Amendments to the Articles of Association
The shareholders further approved the proposals of the Board of Directors to amend the Articles of Association of Rieter Holding Ltd., in order to implement the requirements of the reform of the Swiss company law, which came into force on January 1, 2023.

Carbios, a compnay in the development and industrialization of biological technologies for reinventing the life cycle of plastics and textiles, announces its operating and financial results for the year 2022. The financial statements as of December 31, 2022, were approved by the Company’s Board of Directors at their meeting on April 5, 2023.

• Project to build, in France, the world’s first PET biorecycling plant: Progress in line with 2025 unit commissioning target6
• Excellent results from the demonstration plant validating the industrial scale-up of Carbios technology
• Carbios licensing documentation ready for worldwide industrial and commercial deployment
• Long-term exclusive strategic partnership with Novozymes to ensure supply of enzymes at industrial scale for the Reference Unit and all future licensee plants
• Creation of fiber-to-fiber consortium with On, Patagonia, Puma, PVH Corp., and Salomon
• CE-PET research project successfully completed
• Participation in WhiteCycle project co-funded by Horizon Europe and coordinated by Michelin
• Publication of scientific articles in the prestigious Biophysical Journal and in Chemical Reviews
• Carbios hosts world’s first PET Biorecycling Summit
• Carbios publishes first Sustainability Report and outlines objectives for environmental, social and governance (ESG) initiatives
• Carbios joins Ellen MacArthur Foundation’s circular economy network
• €30 million European Investment Bank loan drawn down in 2022
• Group’s cash position of €101 million as of December 31, 2022

• Revenues: 521.9 million euros (+35%)
• EBITDA before non-recurring items: 98.4 million euros (+51%)
• Net income: 43.8 million euros (+55%)
• Free cash flow before non-recurring items: 43.7 million euros
• Dividend*: €0.48 per share (+33%)

Lectra’s Board of Directors, chaired by Daniel Harari, reviewed the consolidated financial statements for the fiscal year 2022. Audit procedures have been performed by the Statutory Auditors. The certification report will be issued at the end of the Board of Director’s meeting of February 23, 2023.

To facilitate the analysis of the Group’s results, the financial statements are compared to those published in 2021 and to the 2021 pro forma financial statement (“2021 Pro forma”), prepared by integrating the three acquisitions made in 2021 – Gerber Technology (“Gerber”), Neteven, and Gemini CAD Systems (“Gemini”) – as if they had been consolidated from January 1, 2021, whereas they have been consolidated since June 1, July 28 and September 27, 2021 respectively.

See attached document for full report.

• Revenues: 392.1 million euros (+50%)
• EBITDA before non-recurring items: 74.9 million euros (+73%)
• Net income: 35.4 million euros (multiplied by 2.1)
• Free cash flow before non-recurring items: 31.6 million euros

Lectra’s Board of Directors, chaired by Daniel Harari, reviewed the consolidated financial statements for the third quarter and first nine months of 2022, which have not been reviewed by the Statutory Auditors.
To facilitate the analysis of the Group’s results, the financial statements are compared to those published in 2021 and to the 2021 pro forma financial statement ("2021 Pro forma"), prepared by integrating the three acquisitions made in 2021 – Gerber Technology (“Gerber”), Neteven, and Gemini CAD Systems (“Gemini”) – as if they had been consolidated from January 1, 2021, whereas they have been consolidated since June 1, July 28 and September 27, 2021 respectively.

See attached document for full report.